Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma

References

• Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533–43
   PubMed Web of Science ®Google Scholar
• Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184–97
   PubMed Web of Science ®Google Scholar
• IARC working group on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes, and Helicobacter pylori. Lyon: IARC Monogr Eval Carcinog Risks Hum 1994;61:177–241.
   Google Scholar
• Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347–53
   PubMed Web of Science ®Google Scholar
• Huang JQ, Sridhar S, Chen Y, Hunt RH. Metaanalysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114: 1169–79
   PubMed Web of Science ®Google Scholar
• Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a metaanalysis. Am J Gastroenterol 1999; 94: 2373–9
   PubMed Web of Science ®Google Scholar
• Xue FB, Xu YY, Wan Y, Pan BR, Ren J, Fan DM. Association of H. pylori infection with gastric carcinoma: a meta analysis. World J Gastroenterol 2001; 7: 801–4
   PubMed Web of Science ®Google Scholar
• Selbach M, Moese S, Meyer TF, Backert S. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA independent mechanisms. Infect Immun 2002; 70: 665–71
   PubMed Web of Science ®Google Scholar
• Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol 2001; 158: 647–54
   PubMed Web of Science ®Google Scholar
• Ando T, Kusugami K, Ohsuga M, Shinoda M, Sakakibara M, Saito H, et al. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis. Am J Gastroenterol 1996; 91: 1150–6
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297–301
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111–5
   PubMed Web of Science ®Google Scholar
• Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 588–90
   PubMed Web of Science ®Google Scholar
• Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004; 96: 388–96
   PubMedGoogle Scholar
• Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. Br Med J 2003; 326: 737
   PubMed Web of Science ®Google Scholar
• Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457–9
   PubMed Web of Science ®Google Scholar
• Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825–31
   PubMed Web of Science ®Google Scholar
• Misumi A, Murakami A, Harada K, Baba K, Akagi M. Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir 1989; 374: 221–6
   PubMedGoogle Scholar
• Reports on Statistical Co-ordination. Swedish socioeconomic classification. Stockholm: Statistics Sweden (SCB 1982:4).
   Google Scholar
• Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. IARC Sci Publ 1980; 32: 1–338
   Google Scholar
• Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111–5
   PubMed Web of Science ®Google Scholar
• Limburg P, Qiao Y, Mark S, Wang G, Perez-Perez G, Blaser M, et al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001; 93: 226–33
   PubMedGoogle Scholar
• Ekström AM, Held M, Hansson LE, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784–91
   PubMed Web of Science ®Google Scholar
• Rudi J, Kolb C, Maiwald M, Zuna I, von Herbay A, Galle PR, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci 1997; 42: 1652–9
   PubMed Web of Science ®Google Scholar
• Vaucher C, Janvier B, Nousbaum JB, Grignon B, Pezennec L, Robaszkiewicz M, et al. Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: significance of anti-CagA antibodies. Clin Diagn Lab Immunol 2000; 7: 463–7
   PubMedGoogle Scholar
• Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, Stumer T. Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer 2002; 98: 446–9
   PubMed Web of Science ®Google Scholar
• Tatemichi M, Hamada GS, Nishimoto IN, Kowalski LP, Iriya K, Rodrigues JJ, et al. Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non Japanese Brazilians for non-cardia gastric cancer. Cancer Sci 2003; 94: 64–9
   PubMed Web of Science ®Google Scholar
• Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003; 103: 815–21
   PubMed Web of Science ®Google Scholar
• Held M, Engstrand L, Hansson LE, Bergström R, Wadström T, Nyrén O. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?. Helicobacter 2004; 9: 271–7
   PubMed Web of Science ®Google Scholar
• Lopez-Carrillo L, Torres-Lopez J, Galvan-Portillo M, Munoz L, Lopez-Cervantes M. Helicobacter pylori-CagA seropositivity and nitrite and ascorbic acid food intake as predictors for gastric cancer. Eur J Cancer 2004; 40: 1752–9
   PubMed Web of Science ®Google Scholar
• Kikuchi S, Crabtree JE, Forman D, Kurosawa M. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Am J Gastroenterol 1999; 94: 3455–9
   PubMed Web of Science ®Google Scholar
• Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003; 125: 1636–44
   PubMed Web of Science ®Google Scholar
• de Martel C, Llosa AE, Farr SM, Friedman GD, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 2005; 191: 761–7
   PubMed Web of Science ®Google Scholar
• Vieth M, Masoud B, Meining A, Stolte M. Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia?. Digestion 2000; 62: 225–31
   PubMed Web of Science ®Google Scholar
• Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, Schnell J, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50–7
   PubMed Web of Science ®Google Scholar
• Grimley CE, Holder RL, Loft DE, Morris A, Nwokolo CU. Helicobacter pylori associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol 1999; 11: 503–9
   PubMed Web of Science ®Google Scholar
• Loffeld RJ, Werdmuller BF, Kuster JG, Perez-Perez GI, Blaser MJ, Kuipers EJ. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion 2000; 62: 95–9
   PubMed Web of Science ®Google Scholar
• Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000; 95: 387–94
   PubMed Web of Science ®Google Scholar
• Wu DC, Wu IC, Lee JM, Hsu HK, Kao EL, Chou SH, et al. Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol 2005; 100: 588–93
   PubMed Web of Science ®Google Scholar
• Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734–9
   PubMed Web of Science ®Google Scholar
• Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther 1999; 13 Suppl 1: 13–8
   PubMed Web of Science ®Google Scholar
• Papa A, Danese S, Sgambato A, Ardito R, Zannoni G, Rinelli A, et al. Role of Helicobacter pylori CagA+ infection in determining oxidative DNA damage in gastric mucosa. Scand J Gastroenterol 2002; 37: 409–13
   PubMed Web of Science ®Google Scholar
• Davies GR, Simmonds NJ, Stevens TR, Sheaff MT, Banatvala N, Laurenson IF, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179–85
   PubMed Web of Science ®Google Scholar
• Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992; 89: 3030–4
   PubMed Web of Science ®Google Scholar
• Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KE. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994; 35: 317–22
   PubMed Web of Science ®Google Scholar
• Moss SF, Sordillo EM, Abdalla AM, Makarov V, Hanzely Z, Perez-Perez GI, et al. Increased gastric epithelial cell apoptosis associated with colonization with cagA+Helicobacter pylori strains. Cancer Res 2001; 61: 1406–11
   PubMed Web of Science ®Google Scholar
• Naumann M. Pathogenicity island-dependent effects of Helicobacter pylori on intracellular signal transduction in epithelial cells. Int J Med Microbiol 2005; 295: 335–41
   PubMed Web of Science ®Google Scholar
• Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287: 1497–500
   PubMed Web of Science ®Google Scholar
• Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683–6
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM. Corpus gastritis is protective against reflux oesophagitis. Gut 1999; 45: 181–5
   PubMed Web of Science ®Google Scholar
• Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001; 49: 335–40
   PubMed Web of Science ®Google Scholar
• Koike T, Ohara S, Sekine H, Iijima K, Kato K, Shimosegawa T, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 1999; 94: 3468–72
   PubMed Web of Science ®Google Scholar
• Feldman M, Cryer B, Lee E. Effects of Helicobacter pylori gastritis on gastric secretion in healthy human beings. Am J Physiol 1998; 274: G1011–7
   PubMed Web of Science ®Google Scholar